Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
25 November 2020

The UFS SRC Elections will be held from 01 to 04 December 2020 for the QwaQwa and South Campus. The Bloemfontein Campus SRC elections for the elective portfolios will be held in 2021. 

• The window for the nomination of candidates for the CSRC elective portfolios has closed and the final candidate list of candidates is now available on the election website.

• Candidates’ on the final list may therefore conduct their campaigns. Candidates’ campaigns must be within the prescripts of the UFS SRC Election Code of Conduct. 

• Nominations for ex-officio candidates have since closed. In this regard, the final list of candidates will be published on election website on 25 November 2020 

• Student Council Elections for the ex-officio portfolios will be held from 26 to 30 November 2020. To this effect, an invitation to respective student council meetings will be sent out via student emails. 

• Manifesto launches will take place via webinars between 25 and 30 November 2020. A detailed schedule will be made available via the election website.   

KDBS Consulting (Pty) Ltd has been appointed to oversee and manage the SRC elections 2020/2021 as the Independent Chief Elections Administrator. A website has been launched to provide up-to-date information regarding these elections and all processes related to it. The website address is https://www.ufs-srcelection.co.za.

For any queries related to the elections, you can email the Chief Election Administrator at info@ufs-srcelection.co.za  or you can call the election helpdesk at +27 0 800 061 052 toll-free.   

Please look out for election-specific notifications via SMS or your UFS4Life student emails.   

News Archive

Death may come in adorable little packages
2015-03-23

The main host of the Lassa virus is the Natal Mulimammate mouse.

Photo: Supplied

Postdoctoral researcher, Abdon Atangana, of the Institute for Groundwater Studies at the university recently published an article online about the Lassa Haemorrhagic fever in the Natural Computing Applications Forum. In addition to the terminal transmissible sickness recognised as Ebola haemorrhagic fever, there is another strain called Lassa haemorrhagic fever.

The disease is classified under the arenaviridae virus family. The first outbreaks of the disease were observed in Nigeria, Liberia, Sierra Leone, and the Central African Republic. However, it was first described in 1969 in the town of Lassa, in Borno State, Nigeria.

The main host of the Lassa virus is the Natal Mulimammate mouse, an animal indigenous to most of Sub-Saharan Africa. The contamination in humans characteristically takes place through exposure to animal excrement through the respiratory or gastrointestinal tracts.

Mouthfuls of air containing tiny particle of infective material are understood to be the most noteworthy way of exposure. It is also possible to acquire the infection through broken skin or mucous membranes that are directly exposed to the infective material.

“The aim of my research was to propose a novel mathematical equation used to describe the spread of the illness amongst pregnant women in West Africa. To achieve this, I used my newly-proposed derivative with fractional order called beta-derivative. Since none of the commonly used integral transform could be used to derive the solution of the proposed model, I proposed a new integral transform called Atangana-Transform, and used it, together with some iterative technique, to derive the solution of the model.

“My numerical simulations show that the disease is as deadly amongst pregnant women as Ebola,” Abdon said.

Abdon’s research was submitted to one of Springer’s top-tier journals with an impact factor 1.78. The paper was accepted and published February 2015.

Read more about Abdon’s research.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept